Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | AHR | P35869 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 3/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | JAK2 | O60674 | 2/20 | 0.32 |
| ▸ | BCL2 | P10415 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29682017 | 1.00 | CYP2A6 (0.37) | CYP2A6AHRALOX15NR4A2ALDH1A1 | |
| SCHEMBL1539492 | 0.81 | HSP90AA1 (0.42) | CYP2A6AHRALOX15NR4A2ALDH1A1 | |
| SCHEMBL1569950 | 0.77 | MAPK1 (0.36) | CYP2A6AHRNR4A2ALDH1A1MAPK1 | |
| SCHEMBL15056090 | 0.77 | DGAT1 (0.36) | CYP2A6AHRALOX15NR4A2ALDH1A1 | |
| SCHEMBL3872105 | 0.77 | APLNR (0.44) | CYP2A6AHRNR4A2ALDH1A1KMT2A | |
| SCHEMBL24416900 | 0.77 | MAOB (0.39) | CYP2A6AHRNR4A2ALDH1A1MAPK1 | |
| SCHEMBL1539565 | 0.74 | GPR84 (0.33) | ALDH1A1 | |
| SCHEMBL1683312 | 0.74 | GPR84 (0.33) | CSNK2A1GABRA1GABRB1 | |
| SCHEMBL396064 | 0.74 | MAOB (0.44) | CYP2A6AHRNR4A2NOS1MCL1 | |
| SCHEMBL2061830 | 0.72 | GAA (0.41) | ALOX15ALDH1A1MAPK1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250100960-A1 | NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2025-03-27 | — | — | US | disclosed |
| EP-4448504-A1 | NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS | Bristol-Myers Squibb Company (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114818-A1 | NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2016100754-A1 | QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-06-23 | — | — | WO | disclosed |
| EP-2482354-A1 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. du Pont de Nemours and Company (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2482355-A1 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. du Pont de Nemours and Company (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2482354-A1 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. du Pont de Nemours and Company (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2482355-A1 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. du Pont de Nemours and Company (US) | 2012-08-01 | — | — | EP | disclosed |
| US-8053840-B2 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-08 | — | — | US | disclosed |
| US-8053840-B2 | Thin film transistor comprising novel conductor and dielectric compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-08 | — | — | US | disclosed |
| US-5110968-A | NAPHTHALOCYANINE DERIVATIVES, PRODUCTION THEREOF, OPTICAL RECORDING MEDIUM USING THE SAME, AND PRODUCTION THEREOF | HITACHI, CHEMICAL COMPANY LTD. (JP) | 1992-05-05 | — | — | US | disclosed |
| US-5075203-A | Containing sulfone groups; absorbers of laser beams | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1991-12-24 | — | — | US | disclosed |
| US-5039600-A | Solubility in organic solvents, absorption of semiconductor laser light | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1991-08-13 | — | — | US | disclosed |
| US-5034309-A | Used for forming a recording layer | HITACHI CHEMICAL CO., LTD. (JP) | 1991-07-23 | — | — | US | disclosed |
| EP-0378336-A1 | Naphthalocyanine derivatives, production thereof, optical recording medium using the same, and production thereof | Hitachi Chemical Co., Ltd. (JP) | 1990-07-18 | — | — | EP | disclosed |
| EP-0366440-A2 | Naphthalocyanine derivatives, production thereof, optical recording medium using the same, and production thereof | Hitachi Chemical Co., Ltd. (JP) | 1990-05-02 | — | — | EP | disclosed |
| EP-0357360-A2 | Naphthalocyanine derivatives, production thereof and optical recording medium using the same | Hitachi Chemical Co., Ltd. (JP) | 1990-03-07 | — | — | EP | disclosed |
| EP-0296876-A2 | Naphthalocyanine derivatives and their use in optical recording medium | Hitachi Chemical Co., Ltd. (JP) | 1988-12-28 | — | — | EP | disclosed |
| US-4419368-A | 2,2,3,3-TETRAHYDROXY- | SYNTEX (U.S.A.) INC. (US) | 1983-12-06 | — | — | US | disclosed |
| US-4229478-A | Naphthaquinone anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100960-A1 | NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS | RXFP1, RXFP2, RXFP3 | CYP2A6 2264/4885AHR 203/4885ALOX15 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.